Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Nutrigenomics has developed the "Advanced NGx" nutrigenetic test—a clinically validated platform that analyzes an individual's genetic profile to provide actionable dietary recommendations. The company licenses this technology to partners in North America and Europe. The platform uses FDA-approved sequencing hardware and provides reports based on the latest scientific evidence. Clinical results are not therapeutic but relate to the accuracy of gene-based nutritional guidance; no clinical trial outcomes as with drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Nutrigenomics.